Nisa Investment Advisors
ETON icon

Nisa Investment Advisors’s Eton Pharmaceutcials ETON Stock Holding History

Nisa Investment Advisors’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,500
Closed -$12K – 2303
2020
Q4 		$12K Buy
+1,500
New +$11.6K ﹤0.01% 2189

Other funds holding ETON

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

Nisa Investment Advisors's ETON Position: Q1 2021 in Review

Nisa Investment Advisors sold out of Eton Pharmaceutcials (ETON) in Q1 2021, closing a stake of 1,500 shares — an estimated $12K sold.

Nisa Investment Advisors first reported a position in ETON in Q4 2020 and held it in 1 quarter. The position peaked at $12K in Q4 2020. 50 funds tracked by Wall St. Rank hold ETON as of Q1 2021.

  • Nisa Investment Advisors reported no remaining Eton Pharmaceutcials position as of Q1 2021 after selling out during the quarter.
  • Nisa Investment Advisors sold 1,500 Eton Pharmaceutcials shares in Q1 2021, an estimated $12K.
  • Nisa Investment Advisors first reported a position in Eton Pharmaceutcials in Q4 2020 and held it in 1 quarter.
  • Nisa Investment Advisors's Eton Pharmaceutcials position peaked at $12K in Q4 2020.
  • 50 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q1 2021.

Based on Nisa Investment Advisors's 13F filing for Q1 2021, filed 26 Apr 2021.